Category: Cannabis Markets

France is progressing towards establishing a permanent regulatory framework for the medical cannabis market which could generate €806 million in annual revenue by 2035.

Cannabis is legal in Switzerland for medical purposes and the country is currently running seven pilot trials for adult-use cannabis with around 104,000 active participants as of June 2025. Switzerland is also in the process of drafting a new law that if approved would legalize adult-use cannabis use and establish a regulated commercial market.

As of March 2026, some form of medical cannabis (or cannabis-based medicine) is legal in 25 countries across the region, with a further 9 having decriminalised the personal use of cannabis, and 4 having legalised cannabis for recreational use. The European cannabis market grew from €870 million in 2024 to €1.45 billion in 2025 and is projected to surpass €2 billion by 2027.